Sunthetics, a pioneering AI technology company, has announced the successful close of its $4 million Seed round, led by L’ATTITUDE Ventures and joined by S3 Ventures, Hearst Level Up Ventures, and the Global Impact Fund II. The funds will be strategically allocated to expand the Sunthetics team and enhance the company’s innovative machine learning platform, designed to accelerate the pharmaceutical and chemical research and development (R&D) process to drastically cut time-to-market and R&D costs.
Founded by Daniela Blanco, a trailblazing Latina entrepreneur, Sunthetics empowers chemical and pharmaceutical companies with an advanced machine learning platform that leverages small datasets (as few as 5 data points) to create a data-driven roadmap for R&D scientists to achieve better results in a fraction of the time. The platform guides experimentation and identifies viable product pathways with unmatched efficiency, allowing Sunthetics’ partners to bring new products to market dramatically faster than traditional processes, marking a transformative leap in the pace of chemical innovation.
Trusted by the world’s largest pharmaceutical, chemical, and cosmetics companies, as well as leading research institutions, Sunthetics is quickly becoming the industry standard for AI-optimized process development. A top five pharmaceutical company saw 6x faster process development, a 75% reduction in expensive materials, and 12% higher efficiency with Sunthetics and other customers have seen similar results.
Also Read: CVD Equipment Secures $3.5M Follow-On Order
“We invested in Sunthetics because of Daniela’s exceptional ability to simplify and streamline complex chemical processes. Her innovative platform not only accelerates product development but also fosters sustainable practices within the industry,” said Laura Moreno Lucas, general partner at L’ATTITUDE Ventures. “We are confident in her vision to reshape industries and drive meaningful progress toward a sustainable future.”
This landmark investment highlights Sunthetics’ position as a leader in AI-driven chemical research, setting new standards in R&D speed and sustainability within the chemical and pharmaceutical sectors.
Looking ahead, Sunthetics will accelerate its product development and rapid market adoption to play a pivotal role in the chemical industry’s revolution for digital transformation and automated experimentation. “I feel beyond fortunate to work with a team that is visionary, brave, and brilliant. Our team at Sunthetics is what I am most proud of, and I am excited to continue growing our company with the support of strategic and forward-looking investors that believe in our vision. This round will enable us to drive forward our work for a more sustainable and efficient chemical industry,” said Daniela Blanco, CEO, Sunthetics.
Aaron Perman, partner at S3 Ventures, added: “Sunthetics’ next generation platform brings chemical process development into the AI era. We have been blown away by the value that the world’s largest and most sophisticated pharmaceutical and chemical products companies are seeing from Sunthetics. We are excited to partner with Daniela and Sunthetics’ team of deep domain experts as they revolutionize chemical process development.”
SOURCE: PRWeb